Healthcare - Biotechnology - NASDAQ - US
$ 93.17
-4.31 %
$ 4.52 B
Market Cap
-14.16
P/E
CASH FLOW STATEMENT
-145 M
OPERATING CASH FLOW
-582 K
INVESTING CASH FLOW
331 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Axsome Therapeutics, Inc.
| Net Income | -239 M |
| Depreciation & Amortization | 6.83 M |
| Capital Expenditures | -582 K |
| Stock-Based Compensation | 62.6 M |
| Change in Working Capital | -28.4 M |
| Others | 87.9 M |
| Free Cash Flow | -146 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||
| Net Income | (239.2) | (187.1) | (130.4) | (102.9) | (68.3) | (31.0) | (28.9) | (27.2) | (10.6) | (6.0) | (2.2) |
| Depreciation & Amortization | 6.8 | 5.6 | 1.2 | 77.7 K | 37.3 K | 48.9 K | 42.6 K | 20.5 K | 3.54 K | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 1.2 | 0 | (2.8) | 0.6 | 0 | 2.3 | 0 | 0 |
| Stock Based Compensation | 62.6 | 37.7 | 20.8 | 14.8 | 6.1 | 1.8 | 2.1 | 2.0 | 0.8 | 0.4 | 55.3 K |
| Other Operating Activities | 53.1 | 3.7 | (0.1) | 8.0 | 0.6 | 0.4 | 0.5 | 68.9 K | (0.9) | 0.5 | 0.3 |
| Change in Working Capital | (28.4) | 23.7 | 0.3 | 0.4 | 15.2 | 1.5 | (0.8) | 3.8 | 0.9 | 0.5 | 0.2 |
| Cash From Operations | (145.1) | (116.5) | (108.2) | (78.5) | (46.4) | (30.1) | (26.5) | (21.3) | (7.4) | (4.6) | (1.6) |
| INVESTING CASH FLOW | |||||||||||
| Capital Expenditures | (0.6) | (0.7) | (0.3) | 45.9 K | 16.1 K | 32.7 K | 9.9 K | (0.1) | 20.2 K | 0 | 0 |
| Other Items | 0 | (53.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (0.6) | (53.7) | (0.3) | 45.9 K | 16.1 K | 32.7 K | 9.9 K | (0.1) | 20.2 K | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 85.0 | 45.0 | 0 | 28.3 | 12.8 | (3.3) | (0.3) | 10.0 | 7.3 | 5.2 | 3.8 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (12.7) | (4.2) | 11 129 706.6 | 52.8 K | 1.4 | 0.5 | 0.5 | 31.9 K | 12.5 K | 62.5 K | 58 K |
| Cash From Financing Activities | 331.0 | 284.6 | 11.1 | 42.4 | 252.4 | 10.0 | 23.9 | 10.0 | 52.9 | 5.1 | 3.7 |
| CHANGE IN CASH | |||||||||||
| Net Change In Cash | 185.4 | 114.4 | (97.4) | (36.1) | 206.0 | (20.1) | (2.6) | (11.4) | 45.4 | 0.5 | 2.1 |
| FREE CASH FLOW | |||||||||||
| Free Cash Flow | (145.7) | (117.2) | (108.5) | (78.5) | (46.4) | (30.1) | (26.5) | (21.4) | (7.5) | (4.6) | (1.6) |